Skip to content

METHODES ET TECHNIQUES LASER

Active
Private limited companyfounded 2020active for 5 yearsRue de la Bouteillerie(EST) 45A, 7730 Estaimpuis, BelgiumKBO/BCE: BE 0758.467.942
Summary

The computed 12-month bankruptcy probability of METHODES ET TECHNIQUES LASER is 2.5% (moderate). The 2025 annual accounts show equity of €13,579 and a net result of €59,705. Equity is growing by about 25% per year across the filed financial years. Its solvency ranks better than 17% of 2,291 sector peers (NACE 25, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals.

History

On 16 November 2020, METHODES ET TECHNIQUES LASER was incorporated as a private limited company.1 Total assets went from €129,371 in 2021 to €108,420 in 2025 and headcount from 1 to 1 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2021 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
30-09
NBB filing Annual accounts filed
financial year 2025 · micro format · 61 days late
2025
31-12
Financial Highest result from 2021 to 2025net €59,705 ▲266%
Operating result €60,546, net result €59,705, both a record.
31-12
Financial Liquidity more than doubledcurrent ratio 1.39
Current ratio from 0.58 to 1.39; short-term debt falls from €82,338 to €76,866.
16-09
NBB filing Annual accounts filed
financial year 2024 · micro format · 47 days late
2024
30-09
NBB filing Annual accounts filed
financial year 2023 · micro format · 61 days late
2023
31-12
Financial Back to profitnet €1,981
Net result €1,981 after 2 loss-making years.
18-09
NBB filing Annual accounts filed
financial year 2022 · micro format · 49 days late
2022
30-09
NBB filing Annual accounts filed
financial year 2021 · micro format · 61 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.